Bell Rock Capital’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-13,035
| Closed | -$678K | – | 364 |
|
|
2019
Q2 | $678K | Sell |
13,035
-8,495
| -39% | -$442K | 0.6% | 35 |
|
|
2019
Q1 | $1.2M | Buy |
21,530
+5,075
| +31% | +$282K | 0.69% | 43 |
|
|
2018
Q4 | $691K | Buy |
16,455
+4,030
| +32% | +$169K | 0.46% | 51 |
|
|
2018
Q3 | $867K | Sell |
12,425
-925
| -7% | -$64.5K | 0.43% | 57 |
|
|
2018
Q2 | $761K | Sell |
13,350
-4,775
| -26% | -$272K | 0.38% | 60 |
|
|
2018
Q1 | $1.01M | Buy |
18,125
+6,700
| +59% | +$372K | 0.53% | 50 |
|
|
2017
Q4 | $640K | Buy |
11,425
+325
| +3% | +$18.2K | 0.35% | 59 |
|
|
2017
Q3 | $677K | Sell |
11,100
-3,000
| -21% | -$183K | 0.39% | 61 |
|
|
2017
Q2 | $754K | Buy |
14,100
+2,400
| +21% | +$128K | 0.46% | 57 |
|
|
2017
Q1 | $563K | Buy |
11,700
+1,700
| +17% | +$81.8K | 0.52% | 39 |
|
|
2016
Q4 | $400K | Buy |
+10,000
| New | +$400K | 0.42% | 49 |
|